Michael R Kraus

Summary

Country: Germany

Publications

  1. ncbi request reprint Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C
    M R Kraus
    Medizinische Poliklinik, University of Wurzburg, Germany
    Psychosomatics 41:377-84. 2000
  2. ncbi request reprint Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C
    M R Kraus
    Medizinische Poliklinik, University of Wurzburg, Klinikstrasse 6 8, D 97070 Wurzburg, Germany
    Aliment Pharmacol Ther 16:1091-9. 2002
  3. ncbi request reprint Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
    Michael R Kraus
    Clinic for Internal Medicine, University of Wurzburg, Germany
    J Clin Psychiatry 64:708-14. 2003
  4. doi request reprint Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression
    Arne Schäfer
    Medizinische Klinik und Poliklinik II, Department of Gastroenterology, University of Wurzburg, Klinikstr 6 8, D 97070 Wurzburg, Germany
    J Hepatol 52:10-5. 2010
  5. doi request reprint Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C
    Michael R Kraus
    Medizinische Klinik und Poliklinik II, Department of Gastroenterology, University of Wurzburg, Wurzburg, Germany
    Hepatology 58:497-504. 2013
  6. ncbi request reprint Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Michael R Kraus
    Medizinische Poliklinik, University of Wurzburg, Klinikstr 6 8, D 97070 Wurzburg, Germany
    World J Gastroenterol 11:1769-74. 2005
  7. ncbi request reprint Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C
    Michael R Kraus
    Medizinische Klinik und Poliklinik II, Department of Gastroenterology and Hepatology, University of Wurzburg, Wurzburg, Germany
    Gastroenterology 132:1279-86. 2007
  8. ncbi request reprint Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
    Michael R Kraus
    Department of Gastroenterology and Hepatology, Medizinische Poliklinik, University of Wurzburg, D 97070 Wurzburg, Germany
    Clin Pharmacol Ther 77:90-100. 2005
  9. doi request reprint Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review
    Arne Schäfer
    Medizinische Klinik und Poliklinik II, University of Wurzburg, Wurzburg, Germany
    Int J Methods Psychiatr Res 16:186-201. 2007
  10. pmc Nucleoporin p62 antibodies in a case of mixed connective tissue disease
    Doris M Kraemer
    Medizinische Poliklinik, University of Wurzburg, 97070 Wurzburg, Germany
    Clin Diagn Lab Immunol 10:329-31. 2003

Detail Information

Publications16

  1. ncbi request reprint Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C
    M R Kraus
    Medizinische Poliklinik, University of Wurzburg, Germany
    Psychosomatics 41:377-84. 2000
    ..028). Older patients with CHC and patients with a long period since CHC diagnosis or who were advised not to undergo interferon therapy should be carefully and regularly assessed for depression, anxiety, and inappropriate coping styles...
  2. ncbi request reprint Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C
    M R Kraus
    Medizinische Poliklinik, University of Wurzburg, Klinikstrasse 6 8, D 97070 Wurzburg, Germany
    Aliment Pharmacol Ther 16:1091-9. 2002
    ..Psychiatric side-effects may require dose reduction or premature discontinuation of interferon therapy in chronic hepatitis C. New strategies are needed in order to prevent the premature termination of interferon therapy...
  3. ncbi request reprint Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
    Michael R Kraus
    Clinic for Internal Medicine, University of Wurzburg, Germany
    J Clin Psychiatry 64:708-14. 2003
    ..The goal of the present study was to assess prospectively the incidence, spectrum, and extent of psychiatric symptoms of patients receiving interferon alfa therapy as compared with an untreated reference group...
  4. doi request reprint Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression
    Arne Schäfer
    Medizinische Klinik und Poliklinik II, Department of Gastroenterology, University of Wurzburg, Klinikstr 6 8, D 97070 Wurzburg, Germany
    J Hepatol 52:10-5. 2010
    ..The aim of the present study was to investigate the correlation between platelet serotonin (5-hydroxytryptamine, 5-HT) concentrations and IFN-induced depression...
  5. doi request reprint Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C
    Michael R Kraus
    Medizinische Klinik und Poliklinik II, Department of Gastroenterology, University of Wurzburg, Wurzburg, Germany
    Hepatology 58:497-504. 2013
    ..This therefore suggests an added therapeutic benefit of antiviral treatment in HCV infection. Improvement of neurocognitive function may be an additional treatment indication in patients with HCV. (HEPATOLOGY 2013;58:497-504). ..
  6. ncbi request reprint Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
    Michael R Kraus
    Medizinische Poliklinik, University of Wurzburg, Klinikstr 6 8, D 97070 Wurzburg, Germany
    World J Gastroenterol 11:1769-74. 2005
    ..To assess systematically the spectrum and extent of depressive symptoms comparing patient groups receiving peginterferon or conventional interferon...
  7. ncbi request reprint Serotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis C
    Michael R Kraus
    Medizinische Klinik und Poliklinik II, Department of Gastroenterology and Hepatology, University of Wurzburg, Wurzburg, Germany
    Gastroenterology 132:1279-86. 2007
    ..Interferon-induced depression is a major complication in antiviral therapy of chronic hepatitis C. Little is known about underlying mechanisms and reliable predictive factors associated with cytokine-induced depressive symptoms...
  8. ncbi request reprint Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
    Michael R Kraus
    Department of Gastroenterology and Hepatology, Medizinische Poliklinik, University of Wurzburg, D 97070 Wurzburg, Germany
    Clin Pharmacol Ther 77:90-100. 2005
    ..During antiviral therapy of chronic hepatitis C, patients frequently report impairment of concentration or memory. Therefore we prospectively investigated neurocognitive performance in patients receiving interferon alfa and ribavirin...
  9. doi request reprint Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review
    Arne Schäfer
    Medizinische Klinik und Poliklinik II, University of Wurzburg, Wurzburg, Germany
    Int J Methods Psychiatr Res 16:186-201. 2007
    ..Furthermore, objective criteria and guidelines for the treatment of IFN-induced depression in these patients are needed in clinical practice...
  10. pmc Nucleoporin p62 antibodies in a case of mixed connective tissue disease
    Doris M Kraemer
    Medizinische Poliklinik, University of Wurzburg, 97070 Wurzburg, Germany
    Clin Diagn Lab Immunol 10:329-31. 2003
    ..Thus far, p62 antibodies have mainly been described in cases of primary biliary cirrhosis. We speculate that the presence of p62 antibodies is an indication of a poor prognosis in connective tissue disorders...
  11. doi request reprint Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy
    Arne Schäfer
    Department of Gastroenterology and Hepatology, Medizinische Klinik und Poliklinik II, Universitat Wurzburg, Wurzburg, Germany
    Addiction 104:630-40. 2009
    ....
  12. ncbi request reprint Physician-patient relationship and disclosure behaviour in chronic hepatitis C in a group of German outpatients
    Arne Schäfer
    Medizinische Klinik und Poliklinik II, Wurzburg University, Department of Gastroenterology and Hepatology, Germany
    Eur J Gastroenterol Hepatol 17:1387-94. 2005
    ..The goal of the study was to examine self-disclosure of HCV positivity, perceived stigmatization, and potential predictor variables in a German outpatient group...
  13. ncbi request reprint Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study
    Hans Ulrich Wittchen
    Institut für Klinische Psychologie und Psychotherapie, TU Dresden, Germany
    Int J Methods Psychiatr Res 14:14-28. 2005
    ..The COBRA study provides a unique comprehensive database, informing about the natural allocation and intervention processes in routine care and about the course and outcome of patients treated with buprenorphine or methadone...
  14. ncbi request reprint Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?
    Arne Schäfer
    Department of Gastroenterology and Hepatology, Medizinische Klinik und Poliklinik II, Wurzburg, Germany
    Chemotherapy 53:292-9. 2007
    ..The study objective was to determine the contribution of cytokine-induced depression to a predictive model of sustained virological response (SVR) in chronic hepatitis C...
  15. doi request reprint Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients
    Hans Ulrich Wittchen
    Institute of Clinical Psychology and Psychotherapy, Technische Universitaet Dresden, Chemnitzerstrasse 46, 01187 Dresden, Germany
    Drug Alcohol Depend 95:245-57. 2008
    ..Despite many short-term studies, little is known about the long-term (12-month) effects of these treatments in different settings, i.e. primary care-based (PMC) and specialized substitution centers (SSCs)...
  16. ncbi request reprint Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis
    Felix Stickel
    Department of Medicine I, University of Erlangen Nurnberg, Erlangen, Germany
    Arch Intern Med 165:1835-40. 2005
    ..Our objective was to establish the role of the functional polymorphisms of GSTP1 (codon 105 Ile-->Val) and MnSOD (codon 16 of precursor protein Ala-->Val) on the evolution of cirrhosis in patients with HHC and CHC...